Canada markets close in 4 hours 35 minutes

Seelos Therapeutics, Inc. (NXE0.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
2.00000.0000 (0.00%)
As of 08:01AM CEST. Market open.
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-27,115
-37,882
-73,534
-66,048
-19,101
Depreciation & amortization
58
57
53
0
-
Stock based compensation
3,881
3,988
5,073
8,347
2,044
Change in working capital
15,427
12,419
2,783
-1,407
-4,545
Accounts Payable
9,305
12,777
1,933
-194
1,091
Other working capital
-18,206
-23,912
-61,604
-48,995
-20,913
Other non-cash items
-
6,350
4,313
6,989
466
Net cash provided by operating activites
-18,206
-23,912
-61,604
-48,995
-20,913
Cash flows from financing activities
Debt repayment
-7,669
-7,641
-1,888
-13,551
0
Common stock issued
12,300
20,114
457
118,160
26,122
Common stock repurchased
0
-1,195
0
-
-
Other financing activites
-
-
-273
-
-
Net cash used privided by (used for) financing activities
4,671
11,375
-1,597
112,067
26,314
Net change in cash
-13,535
-12,537
-63,201
63,072
5,401
Cash at beginning of period
14,059
15,533
78,734
15,662
10,261
Cash at end of period
524
2,996
15,533
78,734
15,662
Free Cash Flow
Operating Cash Flow
-18,206
-23,912
-61,604
-48,995
-20,913
Free Cash Flow
-18,206
-23,912
-61,604
-48,995
-20,913